Skip to main content
Clinical Trials/ISRCTN12216776
ISRCTN12216776
Completed
未知

Improving person-centred nurse-led care for primary care patients with progressive multimorbid illness

niversity of Birmingham0 sites49 target enrollmentSeptember 30, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Birmingham
Enrollment
49
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2022
End Date
August 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient participants are eligible for inclusion in the study if:
  • 1\. They are 55 years of age or older who are receiving care in the participating primary care sites
  • 2\. People have two or more chronic conditions
  • 3\. All participants have no serious self\-reported cognitive impairment and are cognitively capable of participating in the study
  • 4\. Those who are able to read and speak English fluently and who have access to a smartphone
  • Family caregivers are eligible to participate if they are 18 years old or above and currently providing support for a patient who is receiving care in one of the study sites but cannot self\-report on the IPOS\-APP due to disability or other reasons.
  • Any healthcare professionals working at the participating GP sites will be eligible to take part in this project including nurses, GPs, pharmacists, and so on. Those who have experience of using the clinician portal will be invited for interviews.

Exclusion Criteria

  • Patient participants:
  • 1\. Patients who are outside of stated age range and outside of stated GP sites
  • 2\. Do not have multimorbidity
  • 3\. Are considered by nurses too ill to be approached
  • 4\. Those who are not able to read and speak English
  • 5\. Have no access to a smartphone
  • Caregiver participants:
  • 1\. Family caregivers who are under 18 years old
  • 2\. Caring for patients with no multimorbidity
  • 3\. Outside of stated GP sites

Outcomes

Primary Outcomes

Not specified

Similar Trials